Characterization of clonogenic multiple myeloma cells
Top Cited Papers
Open Access
- 15 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (6), 2332-2336
- https://doi.org/10.1182/blood-2003-09-3064
Abstract
The identity of the cells responsible for the initiation and maintenance of multiple myeloma (MM) remains unclear largely because of the difficulty growing MM cells in vitro and in vivo. MM cell lines and clinical specimens are characterized by malignant plasma cells that express the cell surface antigen syndecan-1 (CD138); however, CD138 expression is limited to terminally differentiated plasma cells during B-cell development. Moreover, circulating B cells that are clonally related to MM plasma cells have been reported in some patients with MM. We found that human MM cell lines contained small (< 5%) subpopulations that lacked CD138 expression and had greater clonogenic potential in vitro than corresponding CD138+ plasma cells. CD138- cells from clinical MM samples were similarly clonogenic both in vitro and in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, whereas CD138+ cells were not. Furthermore, CD138- cells from both cell lines and clinical samples phenotypically resembled postgerminal center B cells, and their clonogenic growth was inhibited by the anti-CD20 monoclonal antibody rituximab. These data suggest that MM “stem cells” are CD138- B cells with the ability to replicate and subsequently differentiate into malignant CD138+ plasma cells.Keywords
This publication has 60 references indexed in Scilit:
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- The mechanisms of action of rituximab in the elimination of tumor cellsSeminars in Oncology, 2003
- Human AML cells in NOD/SCID mice: engraftment potential and gene expressionLeukemia, 2002
- Leukemic stem cells: where have they gone wrong?Blood, 2001
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999
- High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myelomaBritish Journal of Haematology, 1999
- Multiple myeloma: the cells of origin – A two-way streetLeukemia, 1998
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- Multiple myeloma: The biology of malignant plasma cellsBlood Reviews, 1993
- A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitroBritish Journal of Haematology, 1988